Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 151

1.

Exome sequencing and digital PCR analyses reveal novel mutated genes related to the metastasis of pancreatic ductal adenocarcinoma.

Zhou B, Irwanto A, Guo YM, Bei JX, Wu Q, Chen G, Zhang TP, Lei JJ, Feng QS, Chen LZ, Liu J, Zhao YP.

Cancer Biol Ther. 2012 Aug;13(10):871-9. doi: 10.4161/cbt.20839. Epub 2012 Aug 1.

PMID:
22797009
[PubMed - indexed for MEDLINE]
2.

Expression of HOXC8 is inversely related to the progression and metastasis of pancreatic ductal adenocarcinoma.

Adwan H, Zhivkova-Galunska M, Georges R, Eyol E, Kleeff J, Giese NA, Friess H, Bergmann F, Berger MR.

Br J Cancer. 2011 Jul 12;105(2):288-95. doi: 10.1038/bjc.2011.217. Epub 2011 Jun 28.

PMID:
21712827
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.

Ruggeri BA, Huang L, Berger D, Chang H, Klein-Szanto AJ, Goodrow T, Wood M, Obara T, Heath CW, Lynch H.

Cancer. 1997 Feb 15;79(4):700-16.

PMID:
9024708
[PubMed - indexed for MEDLINE]
4.

EP300--a miRNA-regulated metastasis suppressor gene in ductal adenocarcinomas of the pancreas.

Mees ST, Mardin WA, Wendel C, Baeumer N, Willscher E, Senninger N, Schleicher C, Colombo-Benkmann M, Haier J.

Int J Cancer. 2010 Jan 1;126(1):114-24. doi: 10.1002/ijc.24695.

PMID:
19569050
[PubMed - indexed for MEDLINE]
5.

SERPINB5 and AKAP12 - expression and promoter methylation of metastasis suppressor genes in pancreatic ductal adenocarcinoma.

Mardin WA, Petrov KO, Enns A, Senninger N, Haier J, Mees ST.

BMC Cancer. 2010 Oct 12;10:549. doi: 10.1186/1471-2407-10-549.

PMID:
20939879
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Long noncoding intronic RNAs are differentially expressed in primary and metastatic pancreatic cancer.

Tahira AC, Kubrusly MS, Faria MF, Dazzani B, Fonseca RS, Maracaja-Coutinho V, Verjovski-Almeida S, Machado MC, Reis EM.

Mol Cancer. 2011 Nov 13;10:141. doi: 10.1186/1476-4598-10-141.

PMID:
22078386
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Epigenetic regulation and role of metastasis suppressor genes in pancreatic ductal adenocarcinoma.

Mardin WA, Haier J, Mees ST.

BMC Cancer. 2013 May 29;13:264. doi: 10.1186/1471-2407-13-264.

PMID:
23718921
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Mutational activation of K-ras in nonneoplastic exocrine pancreatic lesions in relation to cigarette smoking status.

Berger DH, Chang H, Wood M, Huang L, Heath CW, Lehman T, Ruggeri BA.

Cancer. 1999 Jan 15;85(2):326-32.

PMID:
10023699
[PubMed - indexed for MEDLINE]
9.

Effects of bone sialoprotein on pancreatic cancer cell growth, invasion and metastasis.

Kayed H, Kleeff J, Keleg S, Felix K, Giese T, Berger MR, Büchler MW, Friess H.

Cancer Lett. 2007 Jan 8;245(1-2):171-83. Epub 2006 Feb 20.

PMID:
16488077
[PubMed - indexed for MEDLINE]
10.

MicroRNA-21 is induced early in pancreatic ductal adenocarcinoma precursor lesions.

du Rieu MC, Torrisani J, Selves J, Al Saati T, Souque A, Dufresne M, Tsongalis GJ, Suriawinata AA, Carrère N, Buscail L, Cordelier P.

Clin Chem. 2010 Apr;56(4):603-12. doi: 10.1373/clinchem.2009.137364. Epub 2010 Jan 21.

PMID:
20093556
[PubMed - indexed for MEDLINE]
Free Article
11.

Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas.

Mees ST, Mardin WA, Sielker S, Willscher E, Senninger N, Schleicher C, Colombo-Benkmann M, Haier J.

Ann Surg Oncol. 2009 Aug;16(8):2339-50. doi: 10.1245/s10434-009-0531-4. Epub 2009 May 28.

PMID:
19475450
[PubMed - indexed for MEDLINE]
12.

Inactivation of Smad4 accelerates Kras(G12D)-mediated pancreatic neoplasia.

Kojima K, Vickers SM, Adsay NV, Jhala NC, Kim HG, Schoeb TR, Grizzle WE, Klug CA.

Cancer Res. 2007 Sep 1;67(17):8121-30.

PMID:
17804724
[PubMed - indexed for MEDLINE]
Free Article
13.

Overexpression of fibroblast growth factor receptor 4 in high-grade pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma.

Motoda N, Matsuda Y, Onda M, Ishiwata T, Uchida E, Naito Z.

Int J Oncol. 2011 Jan;38(1):133-43.

PMID:
21109934
[PubMed - indexed for MEDLINE]
14.

Frequencies and prognostic role of KRAS and BRAF mutations in patients with localized pancreatic and ampullary adenocarcinomas.

Schultz NA, Roslind A, Christensen IJ, Horn T, Høgdall E, Pedersen LN, Kruhøffer M, Burcharth F, Wøjdemann M, Johansen JS.

Pancreas. 2012 Jul;41(5):759-66. doi: 10.1097/MPA.0b013e31823cd9df.

PMID:
22699145
[PubMed - indexed for MEDLINE]
15.

Gene expression profiling of microdissected pancreatic ductal carcinomas using high-density DNA microarrays.

Grützmann R, Pilarsky C, Ammerpohl O, Lüttges J, Böhme A, Sipos B, Foerder M, Alldinger I, Jahnke B, Schackert HK, Kalthoff H, Kremer B, Klöppel G, Saeger HD.

Neoplasia. 2004 Sep-Oct;6(5):611-22.

PMID:
15548371
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

The miR-217 microRNA functions as a potential tumor suppressor in pancreatic ductal adenocarcinoma by targeting KRAS.

Zhao WG, Yu SN, Lu ZH, Ma YH, Gu YM, Chen J.

Carcinogenesis. 2010 Oct;31(10):1726-33. doi: 10.1093/carcin/bgq160. Epub 2010 Jul 30.

PMID:
20675343
[PubMed - indexed for MEDLINE]
Free Article
17.

Global microRNA expression profiling of microdissected tissues identifies miR-135b as a novel biomarker for pancreatic ductal adenocarcinoma.

Munding JB, Adai AT, Maghnouj A, Urbanik A, Zöllner H, Liffers ST, Chromik AM, Uhl W, Szafranska-Schwarzbach AE, Tannapfel A, Hahn SA.

Int J Cancer. 2012 Jul 15;131(2):E86-95. doi: 10.1002/ijc.26466. Epub 2011 Nov 19.

PMID:
21953293
[PubMed - indexed for MEDLINE]
18.

Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues.

Aichler M, Seiler C, Tost M, Siveke J, Mazur PK, Da Silva-Buttkus P, Bartsch DK, Langer P, Chiblak S, Dürr A, Höfler H, Klöppel G, Müller-Decker K, Brielmeier M, Esposito I.

J Pathol. 2012 Apr;226(5):723-34. doi: 10.1002/path.3017. Epub 2012 Jan 17.

PMID:
21984419
[PubMed - indexed for MEDLINE]
19.

Increased B cell-activating factor promotes tumor invasion and metastasis in human pancreatic cancer.

Koizumi M, Hiasa Y, Kumagi T, Yamanishi H, Azemoto N, Kobata T, Matsuura B, Abe M, Onji M.

PLoS One. 2013 Aug 6;8(8):e71367. doi: 10.1371/journal.pone.0071367. Print 2013.

PMID:
23940742
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Whole-exome sequencing of human pancreatic cancers and characterization of genomic instability caused by MLH1 haploinsufficiency and complete deficiency.

Wang L, Tsutsumi S, Kawaguchi T, Nagasaki K, Tatsuno K, Yamamoto S, Sang F, Sonoda K, Sugawara M, Saiura A, Hirono S, Yamaue H, Miki Y, Isomura M, Totoki Y, Nagae G, Isagawa T, Ueda H, Murayama-Hosokawa S, Shibata T, Sakamoto H, Kanai Y, Kaneda A, Noda T, Aburatani H.

Genome Res. 2012 Feb;22(2):208-19. doi: 10.1101/gr.123109.111. Epub 2011 Dec 7.

PMID:
22156295
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk